Docetaxel, abiraterone, enzalutamide, apalutamide in patients with metastatic hormone-sensitive prostate cancer
Harkirat Singh TalwarIndian Journal of Urology 2021 37(3):288-290
Source: Indian Journal of Urology - Category: Urology & Nephrology Authors: Harkirat Singh Talwar Source Type: research
More News: Cancer | Cancer & Oncology | Docetaxel | Hormones | India Health | Prostate Cancer | Taxotere | Urology & Nephrology